Tools and Approaches

In addition to providing expanded support for prevention and control programs, USAID supports three critical research efforts: (a) the Agency's Malaria Vaccine Development Program (MVDP) and (b) the development of new drug therapies for malaria, and (c) operations research on behavioral, community, drug use and treatment regimen compliance issues as well as potential community approaches to environmental management of malaria.

The goal of the MVDP is to accelerate progress towards the availability of a malaria vaccine, which can be used as part of malaria control efforts. USAID-supported clinical trials for new treatment therapies for malaria are designed to ensure the timely availability of a malaria vaccine, which can be used as part of malaria control efforts. Similarly, extra funding for ongoing USAID supported clinical trials for new treatment therapies for malaria would ensure the timely availability of alternative treatments for malaria - an increasingly critical issue in light of the emergence and spread of resistance to existing antimalarial drugs. Lastly targeted and expanded operations research efforts will help guide treatment policy and practice, as well as behavior change communication.